Source:http://linkedlifedata.com/resource/pubmed/id/18068301
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-1-9
|
pubmed:abstractText |
Mutations in the parkin gene and the PTEN-induced putative kinase 1 gene (PINK1) have been identified as the most common causes of autosomal recessive early-onset Parkinson disease (EOPD). To investigate the presence of the parkin and PINK1 gene mutation(s) and to explore genotype-phenotype correlations in American Caucasian families with EOPD from North American, we screened these two genes in probands of six families by direct sequencing, semi-quantitative PCR and RT-PCR. No PINK1 gene mutation was found in any of the probands, but compound heterozygous mutations (EX 3 del and EX 3_4 del) in the parkin gene were identified in one family. Extended analysis of the parkin-positive family showed the phenotype of patients was that of classic autosomal recessive EOPD, characterized by early age at onset, slow progression, beneficial response to levodopa, and levodopa-related motor complications. Three heterozygous mutation carriers (EX 3 del or EX 3_4 del) were free of any neurological symptoms. None of 62 healthy controls harbored EX 3 del or EX 3_4 del mutation. Our data suggest that compound heterozygous mutations (EX 3 and EX 3_4 del) in the parkin gene were the cause of EOPD in one of six Caucasian families; heterozygous EX 3 del and heterozygous EX 3_4 del forms were insufficient to cause this disorder, consistent with a loss-of-function mechanism of the parkin mutations. The results may provide new insights into the cause and diagnosis of PD and have implications for genetic counseling.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0304-3940
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
3
|
pubmed:volume |
430
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
18-22
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18068301-Adult,
pubmed-meshheading:18068301-Age of Onset,
pubmed-meshheading:18068301-DNA Mutational Analysis,
pubmed-meshheading:18068301-European Continental Ancestry Group,
pubmed-meshheading:18068301-Female,
pubmed-meshheading:18068301-Genotype,
pubmed-meshheading:18068301-Heterozygote,
pubmed-meshheading:18068301-Humans,
pubmed-meshheading:18068301-Male,
pubmed-meshheading:18068301-Middle Aged,
pubmed-meshheading:18068301-Parkinson Disease,
pubmed-meshheading:18068301-Pedigree,
pubmed-meshheading:18068301-Phenotype,
pubmed-meshheading:18068301-Protein Kinases,
pubmed-meshheading:18068301-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:18068301-Ubiquitin-Protein Ligases,
pubmed-meshheading:18068301-United States
|
pubmed:year |
2008
|
pubmed:articleTitle |
Mutation analysis of the parkin and PINK1 genes in American Caucasian early-onset Parkinson disease families.
|
pubmed:affiliation |
Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|